Published in J Virol on March 01, 2005
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol (2006) 1.40
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol (2006) 1.25
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol (2008) 1.12
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J Virol (2006) 1.05
Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle. J Virol (2006) 1.02
Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J Virol (2011) 1.01
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog (2010) 1.00
Cytomegalovirus UL103 controls virion and dense body egress. J Virol (2011) 0.93
Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor. J Virol (2007) 0.92
Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening. PLoS One (2010) 0.89
Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding. J Virol (2013) 0.88
THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection. PLoS Pathog (2015) 0.81
Role of human cytomegalovirus tegument proteins in virion assembly. Viruses (2014) 0.76
Human Cytomegalovirus pUL47 Modulates Tegumentation and Capsid Accumulation at the Viral Assembly Complex. J Virol (2015) 0.76
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene (1995) 15.67
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell (1993) 11.76
Herpesvirus assembly and egress. J Virol (2002) 6.39
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A (2003) 4.21
The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol (2003) 3.48
Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol (1992) 3.41
Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol (2000) 3.35
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J Virol (2003) 2.72
UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol (1994) 2.69
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48
Structure and assembly of the virion. Intervirology (1996) 2.46
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci U S A (2000) 2.36
Reevaluation of human cytomegalovirus coding potential. Proc Natl Acad Sci U S A (2003) 2.27
Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature (1996) 2.14
The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol (1995) 2.07
Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J (2002) 2.06
Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A (2003) 2.05
Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol (2004) 1.96
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc Natl Acad Sci U S A (2000) 1.91
Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology (1993) 1.83
Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J Virol (1997) 1.79
Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol (1990) 1.76
A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J Virol (1996) 1.74
Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J Virol (2002) 1.60
Regulation of human cytomegalovirus immediate-early gene expression. Intervirology (1996) 1.58
Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol (2000) 1.55
Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect. J Virol (2002) 1.52
Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol (2002) 1.48
Nuclear localization of the human cytomegalovirus tegument protein pp150 (ppUL32). J Gen Virol (1995) 1.47
Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third. J Virol (2001) 1.45
Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J Virol (2000) 1.41
Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J Virol (2002) 1.21
Structural and immunological characterization of the intracellular forms of an abundant 68,000 Mr human cytomegalovirus protein. J Gen Virol (1987) 1.20
Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells. J Gen Virol (1997) 1.19
Human cytomegalovirus TRS1 protein is required for efficient assembly of DNA-containing capsids. J Virol (2004) 1.19
An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol (2003) 1.13
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol (2004) 1.11
The human cytomegalovirus UL35 gene encodes two proteins with different functions. J Virol (2002) 1.09
Effect of sucrose phosphate and sorbitol on infectivity of enveloped viruses during storage. J Clin Microbiol (1983) 1.04
A simple and rapid method for preparation of viral DNA from cell associated cytomegalovirus. J Virol Methods (1999) 0.99
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system. Gastrointest Endosc (2009) 1.89
Hepatic gas gangrene following liver transplantation. Liver Transpl (2007) 1.85
One century of aryne chemistry. Angew Chem Int Ed Engl (2003) 1.81
Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis (2007) 1.78
RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol (2005) 1.72
The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol (2010) 1.70
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis (2004) 1.68
Telomerase gene mutations are associated with cirrhosis formation. Hepatology (2011) 1.67
Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J Virol (2002) 1.57
Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother (2009) 1.55
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion (2010) 1.49
Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant. Leuk Lymphoma (2010) 1.46
C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation (2002) 1.45
Gene silencing by adenovirus-delivered siRNA. FEBS Lett (2003) 1.37
Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane. J Virol (2006) 1.34
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. J Clin Microbiol (2002) 1.34
Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis (2006) 1.28
A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin alpha/beta pathway. J Virol (2003) 1.14
A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res (2009) 1.13
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol (2008) 1.12
GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res (2002) 1.11
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol (2004) 1.11
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant (2005) 1.11
TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol (2013) 1.08
Determinants of endocytic membrane geometry, stability, and scission. Proc Natl Acad Sci U S A (2011) 1.08
Classification of large-time behaviors in a reaction-diffusion system modeling diallelic selection. Math Biosci (2012) 1.08
The influence of space dimension on the large-time behavior in a reaction-diffusion system modeling diallelic selection. J Math Biol (2010) 1.07
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J Virol (2011) 1.07
"Tips and tricks" for high-pressure freezing of model systems. Methods Cell Biol (2010) 1.05
Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res (2002) 1.04
Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis (2008) 1.03
The tegument protein UL71 of human cytomegalovirus is involved in late envelopment and affects multivesicular bodies. J Virol (2011) 1.03
Inactivation and Environmental Stability of Zika Virus. Emerg Infect Dis (2016) 1.03
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01
Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28. J Virol (2003) 1.01
Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation (2009) 1.01
Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. J Biol Chem (2003) 1.00
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis (2010) 0.99
The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochim Biophys Acta (2004) 0.99
Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. J Virol (2012) 0.99
Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J Virol (2013) 0.98
Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany. PLoS One (2011) 0.98
Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol (2007) 0.98
TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology (2002) 0.98
Human cytomegalovirus: host immune modulation by the viral US3 gene. Int J Biochem Cell Biol (2008) 0.97
Isolation and partial purification of the Saccharomyces cerevisiae cytokinetic apparatus. Cytoskeleton (Hoboken) (2010) 0.97
Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor. J Biol Chem (2002) 0.97
Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase. Antimicrob Agents Chemother (2010) 0.96
Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies? J Gen Virol (2006) 0.96
Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus. J Gen Virol (2005) 0.95
Mechanistic investigations of the acid-catalyzed cyclization of a vinyl ortho-quinone methide. Chemistry (2008) 0.95
Large-scale isolation of human hepatocytes for therapeutic application. Cell Transplant (2005) 0.92
Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. Mol Pharmacol (2002) 0.91
Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol (2004) 0.91
Fatal reactivation of postnatal cytomegalovirus infection with rapid emergence of ganciclovir resistance in an infant after allogeneic stem cell transplantation. J Clin Microbiol (2005) 0.91
Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness. Antimicrob Agents Chemother (2009) 0.91
Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. J Virol (2006) 0.90
Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J Immunol (2009) 0.90
The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. J Gen Virol (2005) 0.90
Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis (2003) 0.90
HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res (2005) 0.90
Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation (2011) 0.89
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report. World J Urol (2012) 0.89
Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening. PLoS One (2010) 0.89
Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro. BMC Cancer (2012) 0.89
Quantitative investigation of murine cytomegalovirus nucleocapsid interaction. J Microsc (2007) 0.87
Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing. Antimicrob Agents Chemother (2010) 0.87
Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus. J Virol Methods (2008) 0.85
Cytomegalovirus primary envelopment at large nuclear membrane infoldings: what's new? J Virol (2007) 0.85
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients. Br J Haematol (2004) 0.85
Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology (2014) 0.84
Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study. Clin Infect Dis (2008) 0.84
Analysis of human cytomegalovirus secondary envelopment by advanced electron microscopy. Cell Microbiol (2012) 0.84
Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. Eur Urol (2004) 0.84
Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc Natl Acad Sci U S A (2013) 0.83
Opinion article: cytomegalovirus is a risk factor in atherogenesis. Herpes (2002) 0.83
Effective disinfection of orthodontic pliers. J Orofac Orthop (2006) 0.82
The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner. PLoS One (2012) 0.82
Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients. Nephrol Dial Transplant (2004) 0.82
The 7-transmembrane protein homologue UL78 of the human cytomegalovirus forms oligomers and traffics between the plasma membrane and different intracellular compartments. Arch Virol (2012) 0.82
Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient. BMC Infect Dis (2013) 0.82
Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation. J Med Virol (2006) 0.82
Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. J Virol (2010) 0.81
Nuclear targeting of human cytomegalovirus large tegument protein pUL48 is essential for viral growth. J Virol (2013) 0.81
The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice. J Immunol (2011) 0.81
Well-posedness and qualitative properties of a dynamical model for the ideal free distribution. J Math Biol (2013) 0.81
Human cytomegalovirus infection in human renal arteries in vitro. J Virol Methods (2003) 0.80
Functional cooperation between human adenovirus type 5 early region 4, open reading frame 6 protein, and cellular homeobox protein HoxB7. J Virol (2012) 0.80
Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression. Med Microbiol Immunol (2008) 0.79
Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys. Xenotransplantation (2008) 0.79
Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins. Transpl Int (2006) 0.79
Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient. Antimicrob Agents Chemother (2005) 0.79
Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. Vaccine (2011) 0.79
Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC Infect Dis (2013) 0.78